PHILADELPHIA — The members of the American Association for Cancer Research (AACR) have elected David A. Tuveson, MD, PhD, FAACR, as their President-Elect for 2020–2021. He will officially become President-Elect on April 29, 2020, during the AACR’s Business Meeting of Members. He will assume the presidency in April 2021 at the AACR Annual Meeting in Washington, D.C.

Tuveson is director of the Cold Spring Harbor Laboratory Cancer Center in Cold Spring Harbor, New York, where he is also the Roy J. Zuckerberg Professor of Cancer Research. Additionally, he is chief scientist for the Lustgarten Foundation in Woodbury, New York, the largest pancreatic cancer research philanthropy. Tuveson is a medical staff affiliate at Memorial Sloan Kettering Cancer Center in New York, and also works closely with the Cancer Institute at Northwell Health on Long Island. Additionally, Tuveson serves on the Board of Scientific Advisors of the National Cancer Institute. He is a world-renowned physician-scientist whose basic and translational research focuses on increasing our understanding of the biology of pancreatic cancer and on identifying and testing in preclinical and clinical settings new approaches for diagnosing and treating the disease.

As AACR President-Elect, Tuveson will work with the Board of Directors and the AACR membership, which includes more than 47,000 members in 127 countries, to further the AACR’s mission to prevent and cure all cancers through research, education, communication, collaboration, funding for cancer research, and advocacy.

“I am humbly honored to serve our community as the President-Elect of the AACR. The AACR’s mission is to improve the lives of people worldwide through supporting cancer research and education, and with the AACR’s leadership, much exciting progress has been made over the last 50 years,” said Tuveson. “Sadly, however, many patients still suffer and die from cancer, and additional scientific and logistical challenges need to be overcome in order to improve their outcomes. To articulate and then tackle these new challenges, I look forward to working with trainees, researchers, physicians, educators, policymakers, patients and their advocates, funding agencies, and corporate colleagues. Collectively, we can solve the hardest problems and help the most cancer patients.”

“Dr. Tuveson is a highly distinguished physician-scientist whose pioneering pancreatic cancer research has had an enormous impact on our basic understanding and treatment of this deadly disease,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “His scientific and clinical expertise, together with his visionary leadership and dedication to conquering cancer in all its forms, will be invaluable to the AACR as our organization continues to work toward the goal of preventing and curing all cancers. We are delighted that he has been elected to serve as the AACR’s 2020–2021 President-Elect and our 2021–2022 President.”

More People on the Move